What is the first-line treatment of mild cutaneous lichen amyloidosis?

This protocol addresses mild cutaneous lichen amyloidosis. The primary treatment objective is reduction of pruritus in lichen amyloidosis lesions.

In mild cutaneous lichen amyloidosis, management centres on topical corticosteroid-based therapy. The specific application method and whether localised disease warrants a different approach are part of the structured protocol.

The complete regimen — including application strategies, combination options, and the approach for localised involvement — is available in the full protocol below.